Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Asia Pacific Antibiotics Market By Action Mechanism, By Drug Class, By Country, Industry Analysis and Forecast, 2020 - 2026

Published by KBV Research Product code 988199
Published Content info 101 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Antibiotics Market By Action Mechanism, By Drug Class, By Country, Industry Analysis and Forecast, 2020 - 2026
Published: January 29, 2021 Content info: 101 Pages
Description

The Asia Pacific Antibiotics Market would witness market growth of 6.6% CAGR during the forecast period (2020-2026).

The antibacterial agent is another name of antibiotics that has the capability to kill or slow down bacterial growth. It is widely used for curing and preventing diseases caused by bacteria. The increasing number of patients who are suffering from infectious diseases and the evolution of the latest diagnostic devices are some of the major factors that drive the market.

The antibiotics market is growing owing to the increasing consumption of antibiotics in middle and lower-income countries, huge investments in R&D activities by pharmaceutical companies, and the increasing number of infectious diseases. Although, the development of antibiotic resistance and the rising cost of drug approval hinder the growth of the antibiotic market. On the other hand, advanced prospect molecules and the development of novel combination therapies to cure antibiotic-resistant microbial infections are estimated to propel the market and provide great opportunities for the market players.

With the increasing incidents of infectious diseases, many companies in the market are actively taking efforts for the innovation of advanced products that will propel the growth of the market. There are many infections that become resistant to antibiotics; this situation provides an opportunity for companies to develop advanced products. These advanced products increase the range of treatment by the antibiotics that further support the growth of the market. The innovation of advanced prospect molecules and development of some novel combination therapies which cure antibiotic-resistant infections are expected to support the market growth.

Based on Action Mechanism, the market is segmented into Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors. Based on Drug Class, the market is segmented into Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Johnson and Johnson, Merck & Co., Inc., Pfizer, Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories, F. Hoffmann-La Roche Ltd., and Eli Lilly and Company.

Scope of the Study

Market Segments covered in the Report:

By Action Mechanism

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors,
  • Mycolic Acid Inhibitors

By Drug Class

  • Cephalosporin
  • Penicillin
  • Fluoroquinolone
  • Macrolides
  • Carbapenem
  • Aminoglycosides
  • Sulfonamides,
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Antibiotics Market, by Action Mechanism
    • 1.4.2 Asia Pacific Antibiotics Market, by Drug Class
    • 1.4.3 Asia Pacific Antibiotics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Approvals
    • 3.2.4 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct - 2020, Jul) Leading Players

Chapter 4. Asia Pacific Antibiotics Market by Action Mechanism

  • 4.1 Asia Pacific Cell Wall Synthesis Inhibitors Market by Country
  • 4.2 Asia Pacific Protein Synthesis Inhibitors Market by Country
  • 4.3 Asia Pacific DNA Synthesis Inhibitors Market by Country
  • 4.4 Asia Pacific RNA Synthesis Inhibitors Market by Country
  • 4.5 Asia Pacific Mycolic Acid Inhibitors Market by Country

Chapter 5. Asia Pacific Antibiotics Market by Drug Class

  • 5.1 Asia Pacific Cephalosporin Market by Country
  • 5.2 Asia Pacific Penicillin Market by Country
  • 5.3 Asia Pacific Fluoroquinolone Market by Country
  • 5.4 Asia Pacific Macrolides Market by Country
  • 5.5 Asia Pacific Carbapenem Market by Country
  • 5.6 Asia Pacific Aminoglycosides Market by Country
  • 5.7 Asia Pacific Sulfonamides Market by Country
  • 5.8 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Antibiotics Market by Country

  • 6.1 China Antibiotics Market
    • 6.1.1 China Antibiotics Market by Action Mechanism
    • 6.1.2 China Antibiotics Market by Drug Class
  • 6.2 Japan Antibiotics Market
    • 6.2.1 Japan Antibiotics Market by Action Mechanism
    • 6.2.2 Japan Antibiotics Market by Drug Class
  • 6.3 India Antibiotics Market
    • 6.3.1 India Antibiotics Market by Action Mechanism
    • 6.3.2 India Antibiotics Market by Drug Class
  • 6.4 South Korea Antibiotics Market
    • 6.4.1 South Korea Antibiotics Market by Action Mechanism
    • 6.4.2 South Korea Antibiotics Market by Drug Class
  • 6.5 Singapore Antibiotics Market
    • 6.5.1 Singapore Antibiotics Market by Action Mechanism
    • 6.5.2 Singapore Antibiotics Market by Drug Class
  • 6.6 Malaysia Antibiotics Market
    • 6.6.1 Malaysia Antibiotics Market by Action Mechanism
    • 6.6.2 Malaysia Antibiotics Market by Drug Class
  • 6.7 Rest of Asia Pacific Antibiotics Market
    • 6.7.1 Rest of Asia Pacific Antibiotics Market by Action Mechanism
    • 6.7.2 Rest of Asia Pacific Antibiotics Market by Drug Class

Chapter 7. Company Profiles

  • 7.1 GlaxoSmithKline PLC (GSK)
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
  • 7.2 Johnson and Johnson
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental &Regional Analysis
    • 7.2.4 Research & Development Expenses
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Acquisition and Mergers:
  • 7.3 Merck & Co., Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.1 Recent strategies and developments:
      • 7.3.1.1 Product Launches and Product Expansions:
      • 7.3.1.2 Approvals:
  • 7.4 Pfizer, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Recent strategies and developments:
      • 7.4.4.1 Acquisition and Mergers:
      • 7.4.4.2 Product Launches and Product Expansions:
  • 7.5 Bayer AG
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
  • 7.6 Novartis AG
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Recent strategies and developments:
      • 7.6.4.1 Partnerships, Collaborations, and Agreements:
  • 7.7 Sanofi S.A.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Acquisition and Mergers:
      • 7.7.5.2 Partnerships, Collaborations, and Agreements:
  • 7.8 Abbott Laboratories
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 F. Hoffmann-La Roche Ltd.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Partnerships, Collaborations, and Agreements:
  • 7.10. Eli Lilly and Company
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Regional Analysis
    • 7.10.4 Research & Development Expense

LIST OF TABLES

  • TABLE 1 Asia Pacific Antibiotics Market, 2016 - 2019, USD Million
  • TABLE 2 Asia Pacific Antibiotics Market, 2020 - 2026, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Antibiotics Market
  • TABLE 4 Product Launches And Product Expansions- Antibiotics Market
  • TABLE 5 Approvals- Antibiotics Market
  • TABLE 6 Acquisition and Mergers- Antibiotics Market
  • TABLE 7 Asia Pacific Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
  • TABLE 8 Asia Pacific Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
  • TABLE 9 Asia Pacific Cell Wall Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
  • TABLE 10 Asia Pacific Cell Wall Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
  • TABLE 11 Asia Pacific Protein Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
  • TABLE 12 Asia Pacific Protein Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
  • TABLE 13 Asia Pacific DNA Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
  • TABLE 14 Asia Pacific DNA Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
  • TABLE 15 Asia Pacific RNA Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
  • TABLE 16 Asia Pacific RNA Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
  • TABLE 17 Asia Pacific Mycolic Acid Inhibitors Market by Country, 2016 - 2019, USD Million
  • TABLE 18 Asia Pacific Mycolic Acid Inhibitors Market by Country, 2020 - 2026, USD Million
  • TABLE 19 Asia Pacific Antibiotics Market by Drug Class, 2016 - 2019, USD Million
  • TABLE 20 Asia Pacific Antibiotics Market by Drug Class, 2020 - 2026, USD Million
  • TABLE 21 Asia Pacific Cephalosporin Market by Country, 2016 - 2019, USD Million
  • TABLE 22 Asia Pacific Cephalosporin Market by Country, 2020 - 2026, USD Million
  • TABLE 23 Asia Pacific Penicillin Market by Country, 2016 - 2019, USD Million
  • TABLE 24 Asia Pacific Penicillin Market by Country, 2020 - 2026, USD Million
  • TABLE 25 Asia Pacific Fluoroquinolone Market by Country, 2016 - 2019, USD Million
  • TABLE 26 Asia Pacific Fluoroquinolone Market by Country, 2020 - 2026, USD Million
  • TABLE 27 Asia Pacific Macrolides Market by Country, 2016 - 2019, USD Million
  • TABLE 28 Asia Pacific Macrolides Market by Country, 2020 - 2026, USD Million
  • TABLE 29 Asia Pacific Carbapenem Market by Country, 2016 - 2019, USD Million
  • TABLE 30 Asia Pacific Carbapenem Market by Country, 2020 - 2026, USD Million
  • TABLE 31 Asia Pacific Aminoglycosides Market by Country, 2016 - 2019, USD Million
  • TABLE 32 Asia Pacific Aminoglycosides Market by Country, 2020 - 2026, USD Million
  • TABLE 33 Asia Pacific Sulfonamides Market by Country, 2016 - 2019, USD Million
  • TABLE 34 Asia Pacific Sulfonamides Market by Country, 2020 - 2026, USD Million
  • TABLE 35 Asia Pacific Others Market by Country, 2016 - 2019, USD Million
  • TABLE 36 Asia Pacific Others Market by Country, 2020 - 2026, USD Million
  • TABLE 37 Asia Pacific Antibiotics Market by Country, 2016 - 2019, USD Million
  • TABLE 38 Asia Pacific Antibiotics Market by Country, 2020 - 2026, USD Million
  • TABLE 39 China Antibiotics Market, 2016 - 2019, USD Million
  • TABLE 40 China Antibiotics Market, 2020 - 2026, USD Million
  • TABLE 41 China Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
  • TABLE 42 China Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
  • TABLE 43 China Antibiotics Market by Drug Class, 2016 - 2019, USD Million
  • TABLE 44 China Antibiotics Market by Drug Class, 2020 - 2026, USD Million
  • TABLE 45 Japan Antibiotics Market, 2016 - 2019, USD Million
  • TABLE 46 Japan Antibiotics Market, 2020 - 2026, USD Million
  • TABLE 47 Japan Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
  • TABLE 48 Japan Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
  • TABLE 49 Japan Antibiotics Market by Drug Class, 2016 - 2019, USD Million
  • TABLE 50 Japan Antibiotics Market by Drug Class, 2020 - 2026, USD Million
  • TABLE 51 India Antibiotics Market, 2016 - 2019, USD Million
  • TABLE 52 India Antibiotics Market, 2020 - 2026, USD Million
  • TABLE 53 India Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
  • TABLE 54 India Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
  • TABLE 55 India Antibiotics Market by Drug Class, 2016 - 2019, USD Million
  • TABLE 56 India Antibiotics Market by Drug Class, 2020 - 2026, USD Million
  • TABLE 57 South Korea Antibiotics Market, 2016 - 2019, USD Million
  • TABLE 58 South Korea Antibiotics Market, 2020 - 2026, USD Million
  • TABLE 59 South Korea Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
  • TABLE 60 South Korea Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
  • TABLE 61 South Korea Antibiotics Market by Drug Class, 2016 - 2019, USD Million
  • TABLE 62 South Korea Antibiotics Market by Drug Class, 2020 - 2026, USD Million
  • TABLE 63 Singapore Antibiotics Market, 2016 - 2019, USD Million
  • TABLE 64 Singapore Antibiotics Market, 2020 - 2026, USD Million
  • TABLE 65 Singapore Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
  • TABLE 66 Singapore Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
  • TABLE 67 Singapore Antibiotics Market by Drug Class, 2016 - 2019, USD Million
  • TABLE 68 Singapore Antibiotics Market by Drug Class, 2020 - 2026, USD Million
  • TABLE 69 Malaysia Antibiotics Market, 2016 - 2019, USD Million
  • TABLE 70 Malaysia Antibiotics Market, 2020 - 2026, USD Million
  • TABLE 71 Malaysia Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
  • TABLE 72 Malaysia Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
  • TABLE 73 Malaysia Antibiotics Market by Drug Class, 2016 - 2019, USD Million
  • TABLE 74 Malaysia Antibiotics Market by Drug Class, 2020 - 2026, USD Million
  • TABLE 75 Rest of Asia Pacific Antibiotics Market, 2016 - 2019, USD Million
  • TABLE 76 Rest of Asia Pacific Antibiotics Market, 2020 - 2026, USD Million
  • TABLE 77 Rest of Asia Pacific Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
  • TABLE 78 Rest of Asia Pacific Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
  • TABLE 79 Rest of Asia Pacific Antibiotics Market by Drug Class, 2016 - 2019, USD Million
  • TABLE 80 Rest of Asia Pacific Antibiotics Market by Drug Class, 2020 - 2026, USD Million
  • TABLE 81 Key Information - GlaxoSmithKline PLC (GSK)
  • TABLE 82 Key information -Johnson and Johnson
  • TABLE 83 key information - Merck & Co., Inc.
  • TABLE 84 Key Information - Pfizer, Inc.
  • TABLE 85 Key Information - Bayer AG
  • TABLE 86 Key Information - Novartis AG
  • TABLE 87 Key Information - Sanofi S.A.
  • TABLE 88 Key Information - Abbott Laboratories
  • TABLE 89 key information - F. Hoffmann-La Roche Ltd.
  • TABLE 90 Key Information - Eli Lilly and Company

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
  • FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct - 2020, Jul) Leading Players
  • FIG 5 Recent strategies and developments: Merck & Co., Inc.
  • FIG 6 Recent strategies and developments: Pfizer, Inc.
  • FIG 7 Recent strategies and developments: Sanofi S.A.
Back to Top